Peroxiredoxin2 (Prdx2) Reduces Oxidative Stress and Apoptosis of Myocardial Cells Induced by Acute Myocardial Infarction by Inhibiting the TLR4/Nuclear Factor kappa B (NF-κB) Signaling Pathway

BACKGROUND Peroxiredoxin2 (Prdx2) is an endogenous peroxidase and has been found to reduce the oxidative burden in cells and thereby reduce cell damage and Apoptosis. Therefore, the purpose of this study was to investigate the effect of Prdx2 on the oxidative level and Apoptosis of myocardial cells after acute myocardial infarction (AMI). MATERIAL AND METHODS We constructed an AMI model for Sprague-Dawley rats by ligating the left anterior descending coronary artery. We determined the effect of Prdx2 on AMI by detecting changes in Prdx2 in myocardial tissue via western blot and qRT-PCR. In addition, we used recombinant Prdx2 protein to treat rats and detect changes in oxidative stress and Apoptosis in rat myocardial tissue to verify the protective effect of Prdx2 on the rat heart. RESULTS The protein and mRNA expression of Prdx2 in myocardial tissue of rats in the AMI group was significantly lower than that in the control group. The oxidative and apoptotic levels of myocardial tissue in Prdx2-administered rats were significantly improved compared to the non-administered group, which was manifested by a decrease in Reactive Oxygen Species (ROS) levels and a decrease in the expression of the Caspase family. In addition, Prdx2 also inhibited p65 phosphorylation in myocardial tissues and inhibited TLR4/NF-kappaB signaling pathway activity. CONCLUSIONS The expression of Prdx2 was decreased in myocardial tissue after AMI. Prdx2 can reduce Apoptosis and ROS caused by AMI by inhibiting the TLR4/NF-kB signaling pathway, thereby reducing myocardial injury caused by AMI.